Ex-Merck VP Says No Proof He Lied About Vioxx Study

By Kelly Knaub · June 3, 2014, 9:14 PM EDT

The former vice president of Merck & Co. Inc. has urged a New Jersey federal court to dismiss a securities fraud class action, saying he did not lie to shareholders about...

To view the full article, register now.

Documents

Case Information

Case Title

MERCK & CO., INC., SECURITIES, DERIVATIVE & "ERISA" LITIGATION

Case Number

2:05-cv-01151

Court

New Jersey

Nature of Suit

Labor: Other

Date Filed

February 28, 2005